Tony Hsu - FOUNDER / CHIEF INVESTMENT OFFICER
Tony founded Alethea Capital Management, LLC (“Alethea”) in 2011 after spending nearly fifteen years in the financial services industry. Alethea is an asset management firm catering to major institutions, foundations, and wealthy families. As Founder and CIO, Tony is responsible for developing the strategic vision of the company as well as managing and monitoring portfolio assets on behalf of the firm’s clients. Prior to founding Alethea, he served as a Portfolio Manager at Oppenheimer & Co. Inc. Tony also spent four years with UBS Financial Services, Inc. as Senior Vice President leading the top producing team in the San Diego region. Previously, from 1999 to 2005, he was employed with Deutsche Bank, managing the portfolios of corporate executives and working closely with Deutsche Bank’s quantitative Global Momentum Group in London to build strategies for the firm’s clientele. Tony’s finance career began at Lehman Brothers in 1997 where he was recruited to re-establish Lehman’s presence in Los Angeles following the company’s spinoff from American Express. He holds the Uniform Investment Advisor Law Examination (Series 65). Tony holds a Bachelor of Arts Political Science degree with an emphasis in International Relations from the University of California, Los Angeles. Tony has mentored many under-served children and has championed financial literacy through his “Five-Dollar Challenge™” which has been delivered to hundreds of young adults. He is the Co-Founder of Just In Time For Foster Youth, a leading nonprofit organization that’s been recognized for its significant contributions to San Diego’s emancipated foster youth. He is the Founder and President of the FWD Corporation, a 501(c)(3) organization which supports nonprofit programs and organizations that are driving positive change for at-risk youth. Tony served as Co-Chair of the Nonprofit Institute Advisory Board at the University of San Diego between 2012-2017 and currently serves on several private company boards. He splits his time between San Diego and Seattle where he resides with his wife, three sons, and daughter.
Mark Saad - PARTNER / CHIEF OPERATING OFFICER
Mark joined Alethea Capital Management, LLC (“Alethea”) in 2017 with twenty-five years of executive management and investment banking experience. He is responsible for operations of the firm, working closely with Tony to achieve long-term strategic goals. Mark comes to Alethea from Bird Rock Bio, Inc., (“BRB”) a San Diego based biotechnology company with significant international operations, where he served as Chief Financial Officer since 2014 and had a broad range of operating responsibilities. He was part of the team at BRB which completed a merger-option agreement with Johnson & Johnson in December 2016 and remained with the company through early 2017. Mark began his financial career in New York in 1993 with the investment banking division of Salomon Smith Barney, where he completed a three year financial analyst program and was promoted to Associate. He was recruited by UBS in 1999, where he ascended to the position of Executive Director and Chief Operating Officer of the industry leading Global Healthcare Investment Banking Group. During this time, he gained considerable experience in all aspects of the execution of a wide range of financing and M&A transactions, as well as management of a 100+ person international team. Seeking to transition and augment these skills to directly building companies, in 2004 he accepted the Chief Financial Officer position at Cytori Therapeutics, a San Diego based medical technology company. Over the next ten years, he played a key role in raising more than $250 million both through multiple equity and debt financings as well as strategic transactions. In addition to finance, he oversaw business development, legal, HR, IT and facilities. During this time, Mark was a key part of the formation of a joint venture with Olympus Corporation and served on its Board of Directors. Mark currently serves as a Board Member for Axsome Therapeutics, a New York based publicly traded company, where he assisted in the completion of the company’s IPO in 2015. He has also served as a mentor for Onestart, a leading life sciences and healthcare startup accelerator program. Mark holds a Bachelor of Arts degree in Economics from Villanova University, where he minored in History and was a rower on the Men’s Lightweight Crew team. He resides in San Diego with his wife, son, and two daughters.